Cell-type specific tumorigenesis with Ras oncogenes in human lung epithelial cells

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ras mutations are common oncogenic drivers in cancer.
• Ras isoforms (Hras, Kras, Nras) exhibit distinct mutational frequencies across tissues.
• Kras mutations are prevalent in lung adenocarcinoma but rare in squamous cell carcinoma.

Purpose of the Study:

• Investigate cell-type-specific tumorigenesis of mutant Ras isoforms.
• Elucidate mechanisms of oncogenic signaling in lung adenocarcinoma versus squamous cell carcinoma.
• Determine context dependency of Ras mutations in lung cancer development.

Main Methods:

• Utilized in vitro transformation models with immortalized bronchial epithelial cells (BEC-E6E7/myc) and small airway epithelial cells (SAEC-E6E7/myc).
• Introduced HrasG12V and KrasG12V mutations into epithelial cell models.
• Assessed cell transformation via soft agar and migration assays.
• Analyzed MAPK/ERK and PI3K/AKT signaling pathway activation.

Main Results:

• HrasG12V induced tumorigenesis in BEC-E6E7/myc, while KrasG12V did not.
• SAEC-E6E7/myc showed sensitivity to KrasG12V, but less so to HrasG12V.
• HrasG12V-expressing cells showed elevated MAPK/ERK signaling.
• KrasG12V-expressing cells exhibited increased PI3K/AKT signaling.

Conclusions:

• Oncogenic Ras mutations display cell-type-specific tumorigenesis.
• Lung adenocarcinoma and squamous cell carcinoma exhibit distinct responses to Ras isoforms.
• Signaling pathway activation (MAPK/ERK vs. PI3K/AKT) differs based on Ras mutation and cell type.
• Context dependency influences Ras-driven oncogenic signaling in lung cancer.